Octagos Health, a leading provider of AI-driven cardiac device monitoring solutions, has successfully raised over $43 million in a Series B investment round. The funding was led by Morgan Stanley Expansion Capital, with additional participation from Mucker Capital and other strategic investors. This capital will enable Octagos Health to further advance its innovative cardiac monitoring technology, which leverages artificial intelligence to improve patient outcomes and provide real-time data to healthcare providers.

Healthcare Technology, Private Equity,United States